AGA technical review on nonalcoholic fatty liver disease.
about
Herbal medicines for fatty liver diseasesHerbal medicines for fatty liver diseasesFibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markersPrevalence and determinants of diabetes mellitus among Iranian patients with chronic liver diseaseMicronutrient Antioxidants and Nonalcoholic Fatty Liver DiseaseIncretin based therapies: a novel treatment approach for non-alcoholic fatty liver diseaseSTEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver diseaseHepatic steatosis and fibrosis: Non-invasive assessment.Roles of resolvins in the resolution of acute inflammationNon-alcoholic fatty liver disease: need for a balanced nutritional sourcePrevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in MiceCurcumin eliminates leptin's effects on hepatic stellate cell activation via interrupting leptin signalingSources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.Association between nocturnal hypoxia and liver injury in the setting of nonalcoholic fatty liver disease.Simple scoring system for predicting cirrhosis in nonalcoholic fatty liver disease.Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in JapanNoninvasive investigations for non alcoholic fatty liver disease and liver fibrosis.Ultrasonic elastography in clinical quantitative assessment of fatty liver.Association of hepatitis C virus with insulin resistance: evidences from animal studies and clinical studiesElevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.Nonalcoholic Fatty Liver Disease: Correlation of the Liver Parenchyma Fatty Acid with Intravoxel Incoherent Motion MR Imaging-An Experimental Study in a Rat Model.Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease.Prevalence and factors associated with the presence of non alcoholic fatty liver disease in an apparently healthy adult population in primary care units.Association between PPARGC1A polymorphisms and the occurrence of nonalcoholic fatty liver disease (NAFLD).Risk factors associated with non-alcoholic fatty liver disease in subjects from primary care units. A case-control studyPlasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH).Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.Prevention of steatosis by hepatic JNK1Impact of glucose tolerance on the severity of non-alcoholic steatohepatitis.Modification of a simple clinical scoring system as a diagnostic screening tool for non-alcoholic steatohepatitis in Japanese patients with non-alcoholic fatty liver disease.Prevalence of Nonalcoholic Fatty Liver Disease and its Related Metabolic Risk Factors in Isfahan, IranAssociation of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease.Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 TLow-density lipoprotein particle size in hepatic steatosis and metabolic syndromeActivation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats.Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study.Effect of WeiJia on carbon tetrachloride induced chronic liver injury
P2860
Q24200256-34472751-C888-491B-99DB-BBDFC7D9A370Q24236298-F9758A0D-E424-4029-97BB-F1E4D6C72839Q24644869-34B0B4FC-B390-42F4-B6FB-35CBE06D3C57Q24804864-01CC6481-EB85-411D-8206-FB698686417EQ26738646-91261B61-A35B-4B76-9088-70506CDF96DEQ26827183-5D115012-2677-408D-B811-2EC7F1625AA2Q27478329-85F732CC-AFED-46E2-B1A3-A23C4255B0C7Q27496667-4321D6F8-AFD1-4BA0-9EB9-6DA734A98DB4Q28077200-6EBA7F6B-9D1A-45C8-963A-3A9557939038Q28244502-A4FAF562-E26D-4675-AD7A-3220272D1D1EQ28248994-35A1F7B9-642C-4821-B2CB-A1EEE0DF57B4Q28384968-C05E7319-A6E4-4B42-9032-7D3B1C3872D4Q28552063-AFC049BD-B0A4-429C-827D-B3F6CBF653EFQ28565783-9929EF7A-5EBD-4D1D-BC8C-5192C014F2ECQ29619334-9F462107-AD7F-4807-9F73-B57BC59B20FAQ30418433-8368A64E-CA56-4A3F-88A8-B52D7E4CC881Q30433234-85541021-7BCE-4E35-86D2-F9C634478E8DQ30478139-A20973F1-824A-4D6B-AF26-6E9B28780A11Q30479092-E4E88127-9931-4605-835F-2C11705FAE8CQ30479169-EE7B60B8-6D23-4AF0-87E4-2A06A8F0611AQ30485410-4D2B9E11-F3A7-4153-A156-16092D9FA375Q30572017-62D6F772-DE88-46A4-B4CB-E9FF560CA346Q31004631-62AB8B3D-160F-4BE4-958C-CE00FC9044A1Q33263279-C14B247E-9D88-4F99-A03E-46A1D6382843Q33305022-1B2454B2-18FC-4578-ADCD-1CCD8006B9ACQ33347569-E0554009-74F3-4374-805A-E5CD6F5DCC1AQ33373532-3D239F0C-2802-4F3D-8631-5CFC5BBD2BCCQ33384921-43CBE0D5-E20A-4164-BE3A-B5B80E36692DQ33409801-89E71ECD-4FE4-4131-8580-BE102F3B33D6Q33563333-15813A6D-01E9-46AA-B350-4F26867DA94FQ33580974-85CE2ED9-EF7A-45A8-830F-6A54E41920C6Q33585588-2CA18729-1CB1-42E8-8FDC-E55D02EB6F27Q33607793-74526F4E-E8F0-42C9-81C0-4A4449EB4BD4Q33630744-40583CB8-DC9D-45CD-80A7-8CD43A88C987Q33777486-C43210D8-C98A-47E6-A98D-CC6A72B1F371Q33787851-2AA45D9F-5937-4BBB-A12E-56CEF0700FD6Q33811228-C8C1C5E6-64E2-4425-92AD-0A3E4BB8F4D9Q33836877-19D20204-8DC7-4A0B-BDD0-B20402692E8CQ33845164-6D0DB855-FD35-49EA-84B5-A15E4EF3BEE4Q33866594-FBD56F85-41FC-4EB4-9A1A-28093E8D8862
P2860
AGA technical review on nonalcoholic fatty liver disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
AGA technical review on nonalcoholic fatty liver disease.
@ast
AGA technical review on nonalcoholic fatty liver disease.
@en
AGA technical review on nonalcoholic fatty liver disease.
@nl
type
label
AGA technical review on nonalcoholic fatty liver disease.
@ast
AGA technical review on nonalcoholic fatty liver disease.
@en
AGA technical review on nonalcoholic fatty liver disease.
@nl
prefLabel
AGA technical review on nonalcoholic fatty liver disease.
@ast
AGA technical review on nonalcoholic fatty liver disease.
@en
AGA technical review on nonalcoholic fatty liver disease.
@nl
P356
P1433
P1476
AGA technical review on nonalcoholic fatty liver disease.
@en
P2093
Arun J Sanyal
P304
P356
10.1053/GAST.2002.36572
P407
P577
2002-11-01T00:00:00Z